MARKET

DXR

DXR

DAXOR CORP
AMEX

Real-time Quotes | Nasdaq Last Sale

11.42
0.00
0.00%
Opening 09:30 06/21 EDT
OPEN
--
PREV CLOSE
11.99
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
24.08
52 WEEK LOW
8.58
MARKET CAP
46.07M
P/E (TTM)
-25.3891
1D
5D
1M
3M
1Y
5Y
64 Biggest Movers From Friday
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous glucose monitoring dev...
Benzinga · 06/07 09:09
WPG leads financial gainers, AINC and SRAC among losers
Gainers: Washington Prime Group (WPG) +23%. InnSuites Hospitality Trust (IHT) +13%. Daxor (DXR) +15%. 360 DigiTech (QFIN) +15%. LexinFintech Holdings (LX) +15%.Losers: Pershing Square Tontine Holdings (PSTH) -14%. Ashford (AINC)
Seekingalpha · 06/04 17:13
Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
DaxorCorporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxor's President and Chief Executive Officer will present at the Summer Solstice - Best Ideas from the Buy Side Conference, whi...
GlobeNewswire · 05/28 12:30
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
ACCESSWIRE · 05/27 23:16
Stocks That Hit 52-Week Lows On Thursday
    During Thursday's morning session, 24 stocks hit new 52-week lows.
Benzinga · 05/13 14:11
BRIEF-Daxor Announces Q1 Revenue Jump Of 61% In Its Operating Division Year-Over-Year
reuters.com · 05/13 13:54
Daxor Corporation Announces 61% Increase in Q1 2021 Sales Revenue and Further Acquisitions of its BVA-100(R) Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced a Q1 2021 increase in revenue of 61% in its operating division on a year-over-year basis. In addition, the sales team has recorded the opening of f...
GlobeNewswire · 05/13 13:38
8-K: DAXOR CORP
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT (EDGAR Online via COMTEX) -- Pursuant to Section 13 OR 15(d)...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 05/06 15:17
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DXR. Analyze the recent business situations of DAXOR CORP through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DXR stock price target is 21.50 with a high estimate of 22.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 4
Institutional Holdings: 79.82K
% Owned: 1.98%
Shares Outstanding: 4.03M
TypeInstitutionsShares
Increased
3
6.30K
New
0
0
Decreased
1
2.00K
Sold Out
3
74.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.08%
Healthcare Equipment & Supplies
0.00%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Feldschuh
Chief Financial Officer
Robert Michel
Chief Scientific Officer/Director
Jonathan Feldschuh
Director
Henry Cremisi
Director
Edward Feuer
Independent Director
Joy Goudie
Independent Director
James Lombard
Independent Director
Robert Willens
Declaration Date
Dividend Per Share
Ex-Div Date
12/28/2017
Dividend USD 0.03
01/05/2018
11/18/2016
Dividend USD 0.03
12/20/2016
12/09/2015
Dividend USD 0.04
12/18/2015
11/17/2014
Dividend USD 0.03
12/04/2014
11/15/2013
Dividend USD 0.05
12/05/2013
11/29/2012
Dividend USD 0.1
12/07/2012
08/03/2012
Dividend USD 0.1
08/10/2012
11/08/2011
Dividend USD 0.1
11/16/2011
05/25/2011
Dividend USD 0.15
05/27/2011
11/30/2010
Dividend USD 0.65
12/14/2010
09/02/2010
Dividend USD 0.25
09/13/2010
05/11/2010
Dividend USD 0.1
05/27/2010
--
Dividend USD 1
12/08/2009
--
Dividend USD 0.25
08/21/2009
--
Dividend USD 0.1
05/27/2009
--
Dividend USD 1
12/10/2008
--
Dividend USD 0.25
10/31/2008
--
Dividend USD 0.25
07/24/2008
About DXR
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.

Webull offers kinds of Daxor Corporation stock information, including AMEX:DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.